They dictate compliance, safety, and data needs Pharma cares deeply about real-world evidence, long-term outcomes, adherence, and side-effect monitoring
Recently, Ive seen a lot of patients like Jane: Grappling with obesity and the metabolic diseases cascading from it, they are now among the plurality of Americans who have an FDA indication for semaglutide (the generic name for Ozempic)
Neuroprotective Properties Under Investigation The Zagreb groups 2016 review in Current Neuropharmacology described peripheral BPC-157 administration altering serotonin synthesis rates in specific brain regions, particularly nigrostriatal and other dopaminergic pathways (Tohyama, Sikiric, Diksic, 2004, Life Sciences )
Cong Z, Yuan F, Wang H, Cai X, Zhu J, Tang T, et al